Rocket Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns Rocket Pharmaceuticals Inc (RCKT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 79.7% of the shares are freely tradable; institutional investors hold 89.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RTW INVESTMENTS, LLC | 16.11 | 17,687,772 | +0.0 | 03/31/2026 |
| BlackRock Inc | 7.14 | 7,834,795 | -0.9 | 03/31/2026 |
| Citigroup Inc | 4.65 | 5,107,708 | -2.6 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.27 | 4,690,215 | +0.0 | 03/31/2026 |
| State Street Corp | 4.09 | 4,485,989 | +163.8 | 03/31/2026 |
| Millennium Management LLC | 3.64 | 4,000,344 | +28.3 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.44 | 3,775,736 | +0.0 | 03/31/2026 |
| Maverick Capital Ltd | 3.25 | 3,567,372 | +42.0 | 03/31/2026 |
| Newtyn Management LLC | 2.88 | 3,165,900 | +19.5 | 03/31/2026 |
| Nuveen, LLC | 2.85 | 3,128,753 | +1,880.1 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Shah Gaurav | CEO | 1,056,594 | 3,698,079 $ | Aug 18, 2026 | direct |
| Wilson Martin | General Counsel | 598,489 | 2,094,712 $ | Sep 11, 2026 | direct |
| Stevens Christopher James | Chief Operating Officer | 505,784 | 1,770,244 $ | Aug 11, 2026 | direct |
| Chaudhuri Sarbani | See Remarks | 262,809 | 919,832 $ | Aug 11, 2026 | direct |
| Southwell David P | Director | 204,522 | 715,827 $ | Aug 3, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Wilson Martin | General Counsel | Sell | 75,364 | 3.40 | 256,464 |
| Aug 18, 2026 | Wilson Martin | General Counsel | Sell | 631 | 3.38 | 2,133 |
| Aug 18, 2026 | Shah Gaurav | CEO | Sell | 2,293 | 3.38 | 7,753 |
| Aug 13, 2026 | Shah Gaurav | CEO | Sell | 2,837 | 3.38 | 9,592 |
| Aug 13, 2026 | Wilson Martin | General Counsel | Sell | 3,493 | 3.38 | 11,810 |
| Aug 11, 2026 | Stevens Christopher James | Chief Operating Officer | Sell | 36,658 | 3.50 | 128,266 |
| Aug 11, 2026 | Chaudhuri Sarbani | See Remarks | Sell | 4,701 | 3.50 | 16,449 |
| Aug 3, 2026 | Stevens Christopher James | Chief Operating Officer | Other | 73,313 | 0.00 | – |
| Aug 3, 2026 | Southwell David P | Director | Other | 150,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.